Among people who received mRNA-1273, the incidence of symptomatic COVID-19 was 94.1% lower than among those who received placebo, investigators report in The New England Journal of Medicine.
Medscape Medical News
Among people who received mRNA-1273, the incidence of symptomatic COVID-19 was 94.1% lower than among those who received placebo, investigators report in The New England Journal of Medicine.
Medscape Medical News